Absorption Capacity Testing for Chemistry

Categories:

Related Services:

Test Description

Absorption Capacity Testing in medical device chemistry evaluates how much fluid a device can absorb under specific conditions. This is critical for absorbable or fluid-interacting devices, ensuring they perform safely and effectively in clinical settings. The test helps identify extractable compounds that may migrate from the device into the body, supporting toxicological risk assessments. It is often part of broader chemical characterization and biocompatibility evaluations, especially for absorbable materials that degrade or dissolve. Accurate testing informs regulatory submissions and helps manufacturers meet safety standards for patient exposure and device reliability.

Why This Testing is Performed

Absorption capacity testing is essential for understanding how medical devices—especially absorbable ones—interact with bodily fluids. It helps determine the point of exhaustion in extractables studies, ensuring that all potentially harmful compounds are identified before the device is approved for use. For absorbable materials, which degrade through hydrolysis, oxidation, or enzymatic reactions, this testing ensures that dissolution doesn’t obscure chemical risks.

 


Have you tried our Test Navigator Tool? Try it now


 

Steps in Conducting This Test

  1. Sample Preparation: Devices are tested in their final form or representative subcomponents, following ISO 10993-12 guidelines.
  2. Extraction: Using solvents or media to simulate body conditions, the device is subjected to exhaustive extraction until ≥90% of extractables are recovered.
  3. Chemical Analysis: Techniques like FTIR, HPLC, GC-MS, and ICP are used to identify and quantify extractables.
  4. Interpretation: Results are assessed for toxicological relevance and used to inform biocompatibility evaluations.

Standards, Guidance, and Regulations

  • ISO 10993-12: Sample preparation and extraction protocols
  • ISO 10993-5/-10/-17: Biocompatibility and toxicological risk assessment standards
  • FDA Guidance (2023 Draft): Chemical analysis for biocompatibility assessment
Test Code
C-ABS-CAP